Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trimetazidine in Pulmonary Arterial Hypertension
NCT03273387Phase 3Completed
- Sponsor
- Universitas Indonesia
- Start
- Sep 2017
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of trimetazidine in pulmonary arterial hypertension (PAH), sponsored by Universitas Indonesia. Started Sep 2017; status: completed.
02
Drugs
trimetazidine
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT03273387.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03273387.